CompletedPhase 2NCT01011309

A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Access to Advanced Health Institute (AAHI)
Principal Investigator
Franco Piazza, MD, MPH
Access to Advanced Health Institute (AAHI)
Intervention
LEISH-F2 + MPL-SE(biological)
Enrollment
45 target
Eligibility
18-70 years · All sexes
Timeline
2009 – 2011

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01011309 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials